DAY ONE BIOPHARMACEUTICALS, INC.: cashflow_financing
| Value | {"amount": 203291000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | DAY ONE BIOPHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:35:13.782524+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/21872f63-0024-40d7-aebd-7e696d17c7fd
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-25-026654Retrieved: 2026-08-19T18:35:13.782524+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001845337/cashflow-financing/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/21872f63-0024-40d7-aebd-7e696d17c7fd
History
- no predecessors — first report